Europe PMC
open access
A product control framework for extracellular vesicle therapeutics: Quality attributes, stability, analytical procedures, and biodistribution
Extracellular vesicle (EV) therapeutics are being developed as native or minimally modified products and as engineered delivery systems, yet their composition and activity depend strongly on source cells, manufacturing, formulation, and storage. This review examines how established pharmaceutical an
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Detection of Extracellular Vesicles with Colocalized Surface Markers via a Capture–Release–Capture Strategy for Treatment Monitoring in Ewing Sarcoma#1106783
- Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer#890570
- Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms#866114
- Real-world efficacy of nanoliposomal irinotecan in patients with advanced pancreatic cancer#159283
- Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases#1096295
Record · ID 780626
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive